Understanding and Predicting Breast Cancer Events After Treatment (NCT02791581)

🧪 Interventions in This Study

• Cardiac MRI (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (66 Sites)

Showing the first 25 of 66 sites.

• University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
• MedStar Washington Hospital Center — Washington D.C., District of Columbia
• Moffitt Cancer Center - McKinley Campus — Tampa, Florida
• Moffitt Cancer Center — Tampa, Florida
• Northwestern University — Chicago, Illinois
• IU Health North Hospital — Carmel, Indiana
• Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana
• Springmill Medical Center — Indianapolis, Indiana
• University of Kansas Cancer Center — Kansas City, Kansas
• University of Kansas Hospital-Westwood Cancer Center — Westwood, Kansas
• Tufts Medical Center — Boston, Massachusetts
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan
• Beaumont Hospital - Dearborn — Dearborn, Michigan
• Beaumont Hospital - Farmington Hills — Farmington Hills, Michigan
• Spectrum Health at Butterworth Campus — Grand Rapids, Michigan
• William Beaumont Hospital-Royal Oak — Royal Oak, Michigan
• William Beaumont Hospital - Troy — Troy, Michigan
• Saint John's Hospital - Healtheast — Maplewood, Minnesota
• Abbott-Northwestern Hospital — Minneapolis, Minnesota
• Health Partners Inc — Minneapolis, Minnesota
• Regions Hospital — Saint Paul, Minnesota
• United Hospital — Saint Paul, Minnesota
• Minnesota Oncology Hematology PA-Woodbury — Woodbury, Minnesota
• Morristown Medical Center — Morristown, New Jersey
• Newton Medical Center — Newton, New Jersey

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Breast Cancer

• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
• [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
• Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
• TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
• A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
• ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California

Explore by condition: All Breast Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.